Literature DB >> 2517922

Variation in HLA expression on tumors: an escape from immune response.

M E Smith1, J G Bodmer, A P Kelly, J Trowsdale, S C Kirkland, W F Bodmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2517922     DOI： 10.1101/sqb.1989.054.01.069

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN： 0091-7451


× No keyword cloud information.
  5 in total

Review 1.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines.

Authors:  M J Browning; P Krausa; A Rowan; D C Bicknell; J G Bodmer; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

3.  Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.

Authors:  S Apasov; M Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  The effect of class II gene transfection on the tumourigenicity of the H-2K-negative mouse leukaemia cell line K36.16.

Authors:  R F James; S Edwards; K M Hui; P D Bassett; F Grosveld
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

5.  Reduced stimulation of helper T cells by Ki-ras transformed cells.

Authors:  D J Maudsley; W J Bateman; A G Morris
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.